108
Views
49
CrossRef citations to date
0
Altmetric
Research Article

Niosomal delivery of 5-fluorouracil

Pages 731-740 | Published online: 29 Sep 2008

References

  • AZMIN M. N., FLCRENCL A. T., HANDIANE-VILA, R. M, STUART, J. F. B., VANLERBERGM G., and WHTTAKER, J. S., 1985, The effect of non-ionic surfactant vesicles (niosomes) entrapment on the absorption and distribution of methotrexate in mice. Journal of Pharmacy and Pharmacology, 37, 237–242.
  • BAILLIE, A. J., CalvES, G H., DCLAN T. F., and LAURIE J., 1986, Nonionic surfactant vesicles, niosomes, as a delivery system for the antileishmanial drug sodium stibogluconate. Journal of Pharmacy and Pharmacology, 38, 502–505.
  • BAILLIE, A. J., FLCREINM A. T., HUNt L. R., MURHEAll G., and RCGERSCN A., 1985, The preparation and properties of niosomesnon ionic surfactant vesicles. Journal ofPharmacy and Pharmacology, 37, 863–868.
  • BETAGERI, G V, and PARSCM D. L., 1992, Drug encapsulation and release from multilamellar and unilamellar liposames. International Journal of Pharmaceutics, 81, 235–241.
  • CHANDRAFRAKASTA K S., UDUPA, N., UMADEVI, P., and RUA G K, 1990, Pharmacokinetic evaluation of surfactant vesicle entrapped methotrexate in tumor bearing mice. International Journal of Pharmaceutics, 61, R1—R2.
  • CHANDRAFRAKASIA K S., UDUPA, N., UMADEVI,, P, and RIAI, G K, 1992, Formulation and evaluation of methotrexaste niosomes. Indian Journal of Pharmaceutical Sciences, 54, 197–200.
  • ECHEGOYEN L. E., HERNANEE4 J. C., KAIFER, A. E GCKEL, G. W., and BIBOCriml L., 1988, Aggregation of steroidal ethers: The first example of nonionic liposomes(niosomes) formed from neutral crown ether compounds. Journal of Chemical Society and Chemical Communication, 12, 836–837.
  • HANDIAN-VIIA, R. M., RIMIER, A., RcNcor, B. A., and VANLERBERGM G., 1979, Dispersion of lamellar phase of nonionic lipids in cosmetic products. International Journal of Cosmetic Sciences; 1, 303–314.
  • HARDNAN J. G, and LIWEIRD L. E. (ed. in chief), 1996, Goodman & Gilman's The Pharmacological basis of Therapeutics (McGraw-Hill, New York) p. 1249.
  • HEATH-TIMOTY, D., LC1E4 N G., and PAPAHADKICULCS, D., 1985, The effect of liposome size and surface charge on liposome mediated delivery of methotrexate aspartate to cell in-vitro. Biochimica et Biophysica Acta, 820, 74–84.
  • HCELAND H. E. J., BCUMIRA J. A., PLNEc M, BCDM H E, SHE, F., VERIEEF, H., and JUNGINJER, H E., 1991, Interaction of nonionic surfactant vesicles with cultured keratinocytes and human skin in-vitro a survey of toxicologic aspects and ultrastructural changes in stratum corneum. Journal of Controlled Release, 16, 155–168.
  • HCFLAND H E. J., BCRISIBA J. A., VERLEEF, J. C., BUCKFCN G, ClUivaRY, B. Z, PCNEc M, and JUNG-Nall, H. E., 1992, Safety aspects of nonionic surfactant vesicles A toxicity study related to the physicochemical characteristics of nonionic surfactant. Journal of Pharmacy and Pharmacology, 44, 287–294.
  • HUNITR, C. A., DCIAN T. E, CCCMK G H., and BAILLM A. J., 1988, Vesicular systems (niosomes and liposames) for delivery of sodium stibogluconate in experimental murine visceral leislimaniasis. Journal of Pharmacy and Pharmacology, 40, 161–165.
  • KIWADA H., NIWURA, H., FIESAKL Y., YAMADA, Y., and KAIQ Y., 1985b, Application of synthetic alkyl glycoside vesicles as drug carriers: Preparation and physical properties Chemical and Pharmaceutical Bulletin, 33, 753–759.
  • KIWADA H, NHVLRA. H, and KATQ Y., 1985a, Tissue distribution and pharmacokinetic evaluation of the targeting efficiency of synthetic alkyl glycoside vesicles Chemical and Pharmaceutical Bulletin, 33, 2475–2482.
  • KULKARN, S. B., BETAGERI, G V., and SINGH M., 1995, Factors affecting micro-encapsulation of drugs in liposomes. Journal of Microencapsulation, 12, 229–246.
  • NOTARI, R. F., 1987, Biopharmaceutics and Clinical Pharmacokineticsan Introduction (NewYork Marcel Dekker).
  • PARTHASARTH, G., UEUPA N., and PHIAL G. K, 1994, Formulation and in vitro evaluation of vincristine encapsulated niosomes. Indian Journal of Pharmaceutical Sciences; 30, 90–94.
  • RAJANABESIA R. A., SINal U. V., UEUPA N, and PHIAL G. K, 1993, Anti-inflammatory activity of niosome encapsulated diclofenac sodium in rats. Indian Drugs, 30,275–278.
  • RUDY, C. B., and SENKOASKE, B. Z, 1972, Analytical profiles of drug substances (New York Academic Press), p. 221.
  • SADEE, and BEELEN G. C. M, 1980, Drug level monitoringAnalytical Techniques,metabolsim and pharmacokinetics (USA Wiley).
  • SZOKA, F., and PAPAHADTCFCULCS, D., 1980, Comparative properties and methods of preparation of lipid vesicles(liposames). Annual Review of Bioengineering, 9, 467–508.
  • TSUKADN, K, UBDA S., and OKADA R., 1984, Preparation of liposome encapsulated antitumor drugs: Relationship between lipophilicity of drugs and in vitro drug release. Chemical and Pharmaceutical Bulletin, 32, 1929.
  • UCHEGBU I. F., and DCUEL J. A., 1997, Niosomes containing N-(2-hydroxypropyl) methacrylamide copolymer-doxorubicin (PK1): effect of method of preparation and choice of surfactant on niosome characteristics and a preliminary study of body distribution. International Journal of Pharmaceutics, 155, 7–17.
  • UCHEGBU J. F. DCUBLE, J. A., TLRTCNT J. A., and FLCRENt A. T., 1995, Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse. Pharmaceutical Research, 12, 1019–1024.
  • UNITED SMUTS PHARMKECICETA 23-NATICNAL FCRMULARY, 1995 (Rockville: United States Pharmacopoeial Convention), p. 679.
  • YCSHICKA, T., SIBINBERQ B., MCCDY, M., and FLCRENt A. T., 1992, Niosomes from Span surfactants: Relations between structure and form. Journal of Pharmacy and Pharmacology supplement, 44, 1044.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.